United States· US:11788-150_6c8521c7-d18f-4416-bcd3-9f55e17ec90b

Cholestyramine

A medicinal product containing cholestyramine, registered in United States by AiPing Pharmaceutical, Inc..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCholestyramineATC—REGISTER NO.US:11788-150_6c8521c7…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CHOLESTYRAMINE
Manufacturer
AiPing Pharmaceutical, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    11788-150-17
  • ndc11
    11788-150-60

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cholestyramine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cholestyramine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Quantalan Zuckerfrei
  • Belgium · Questran
  • Cyprus · Resincolestiramina
  • Germany · Colestyramin 1 A Pharma, Colestyramin Ratiopharm
  • Denmark · Colestyramin Orifarm
  • Spain · Efensol, Resincolestiramina
  • Finland · Questran
  • France · Questran
  • United Kingdom (Northern Ireland) · Colestyramine Light Laboratorios Rubió, Colestyramine Neon Healthcare
  • Hungary · Cholestyramine
  • Ireland · Questran
  • Italy · Questran
  • Luxembourg · Questran
  • Netherlands · Colestyramine Suikervrij Focus, Questran
  • Norway · Questran, Questran Loc
  • Portugal · Quantalan
  • Sweden · Kolestyramin Alternova, Questran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4a7e7cb-7174-422c-8a4a-3fe2c6263a3c
GET /v1/drugs/e4a7e7cb-7174-422c-8a4a-3fe2c6263a3c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "4",
  "substance": "CHOLESTYRAMINE",
  "productndc": "11788-150",
  "dosage_form": "POWDER, FOR SUSPENSION",
  "dea_schedule": null,
  "strength_unit": "g/9g",
  "application_number": "ANDA214877",
  "marketing_category": "ANDA"
}

See everything about cholestyramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.